Tuesday, July 19, 2011 6:41:44 PM
NVAX gained 7.58% on 07/19/11 and a total percentage of 8.68% in the past 2 days
NVAX is trading in the range of $1.84 - $2.23 in the past 30 days.
NVAX formed a Three Outside Up pattern.
Average True Range (Atr) indicates the volatility has increased for NVAX.
Commodity Channel Index (CCI) is bullish for NVAX.
Money Flow Index (MFI) is bullish and moving up for NVAX.
The 10-day simple moving average is bullish and moving up for NVAX.
Average volume increase over 10% for NVAX.
Stock performance base on day of week in the past 90 days.
Monday: -5.49%
Tuesday: 13.15%
Wednesday: -15.83%
Thursday: 4.11%
Friday: -12.58%
NVAX is trading in the range of $1.84 - $2.23 in the past 30 days.
NVAX formed a Three Outside Up pattern.
Average True Range (Atr) indicates the volatility has increased for NVAX.
Commodity Channel Index (CCI) is bullish for NVAX.
Money Flow Index (MFI) is bullish and moving up for NVAX.
The 10-day simple moving average is bullish and moving up for NVAX.
Average volume increase over 10% for NVAX.
Stock performance base on day of week in the past 90 days.
Monday: -5.49%
Tuesday: 13.15%
Wednesday: -15.83%
Thursday: 4.11%
Friday: -12.58%
Recent NVAX News
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 05/07/2026 09:03:47 PM
- Novavax to Participate in BofA Securities 2026 Health Care Conference • PR Newswire (US) • 05/07/2026 08:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/06/2026 12:00:27 PM
- Novavax Reports First Quarter 2026 Financial Results and Operational Highlights • PR Newswire (US) • 05/06/2026 12:00:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/06/2026 11:50:51 AM
- Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors • Edgar (US Regulatory) • 04/30/2026 04:07:17 PM
- Novavax to Report First Quarter 2026 Financial Results on May 6, 2026 • PR Newswire (US) • 04/29/2026 08:00:00 PM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 04/27/2026 12:00:48 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 04/27/2026 12:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/16/2026 10:13:00 PM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 04/16/2026 09:40:20 PM
- Novavax shares rise as activist investor calls for board overhaul • IH Market News • 04/08/2026 02:23:16 PM
- Form SCHEDULE 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend] • Edgar (US Regulatory) • 04/08/2026 10:00:09 AM
- Novavax Appoints Dr. Robert Walker as Executive Vice President and Head of Research & Development • PR Newswire (US) • 03/30/2026 12:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/12/2026 09:00:14 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/09/2026 10:13:36 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/05/2026 11:04:04 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/05/2026 11:03:17 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/05/2026 11:02:23 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/05/2026 11:01:36 AM
